Los Alamos, NM, United States of America

Konstantinos Lymperopoulos


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Konstantinos Lymperopoulos in Biocontrol Technology.

Introduction

Konstantinos Lymperopoulos is an innovative inventor based in Los Alamos, NM (US). He has made significant contributions to the field of biocontrol technology, particularly in the fight against disease-transmitting mosquitoes. His work focuses on utilizing genetically engineered symbiotic bacteria to deliver pathogen-specific interfering RNA molecules.

Latest Patents

Lymperopoulos holds a patent for a system designed for the biocontrol of disease-transmitting mosquitoes and their eggs. The patent, titled "System for the biocontrol of disease-transmitting mosquitoes and their eggs using horizontally transferable symbiotic bacteria to deliver pathogen specific interfering RNA polynucleotides," outlines a novel paratransgenic strategy for controlling pathogens. This inventive technology aims to deliver inhibitory RNA molecules to mosquitoes, thereby reducing the transmission of diseases.

Career Highlights

Throughout his career, Konstantinos Lymperopoulos has worked with notable organizations such as Pebble Labs Inc. and the Colorado State University Research Foundation. His experience in these institutions has allowed him to develop and refine his innovative approaches to biocontrol.

Collaborations

Lymperopoulos has collaborated with esteemed colleagues, including Richard Thomas Sayre and Jiannong Xu. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.

Conclusion

Konstantinos Lymperopoulos is a prominent figure in the field of biocontrol technology, with a focus on innovative solutions for combating disease-transmitting mosquitoes. His contributions through patents and collaborations highlight the importance of scientific research in addressing public health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…